PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

In the past decade, a growing body of literature has reported promising results for prostate-specific membrane antigen (PSMA)-targeted radionuclide imaging and therapy in prostate cancer. First clinical studies evaluating the efficacy of [(177)Lu]Lu-PSMA radioligand therapy (PSMA-RLT) demonstrated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Uijen, M. J. M., Derks, Y. H. W., Merkx, R. I. J., Schilham, M. G. M., Roosen, J., Privé, B. M., van Lith, S. A. M., van Herpen, C. M. L., Gotthardt, M., Heskamp, S., van Gemert, W. A. M., Nagarajah, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566635/
https://www.ncbi.nlm.nih.gov/pubmed/34120192
http://dx.doi.org/10.1007/s00259-021-05433-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566635/
https://www.ncbi.nlm.nih.gov/pubmed/34120192
http://dx.doi.org/10.1007/s00259-021-05433-w

Ejemplares similares